Literature DB >> 9767638

Substituted 4-acylpyrazoles and 4-acylpyrazolones: synthesis and multidrug resistance-modulating activity.

P Chiba1, W Holzer, M Landau, G Bechmann, K Lorenz, B Plagens, M Hitzler, E Richter, G Ecker.   

Abstract

A series of 4-acyl-3-pyrazolone derivatives with a 3-substituted 2-hydroxy-3-aminopropyl chain attached to pyrazole N-1 (7-20) as well as isomeric 4-acyl-5-(3-substituted 3-amino-2-hydroxypropoxy)pyrazole derivatives (5, 6) were synthesized, and their multidrug resistance (MDR)-modulating activity was measured using the daunomycin efflux assay. Reaction of N1-substituted 4-acyl-3-pyrazolones (tautomer to 4-acyl-5-hydroxypyrazoles) with excessive epichlorohydrin and successive treatment with an appropriate amine resulted in N-alkylation and thus afforded the target pyrazolone derivatives 7-20. In contrast, O-alkylation occurred upon reaction with 1 equiv of epichlorohydrin and subsequent treatment with amine leading to the corresponding 4-acyl-5-pyrazolyl ethers 5 and 6. QSAR studies showed a good correlation of MDR-modulating activity with lipophilicity of the compounds. Inclusion of hydrogen bond acceptor strength and steric parameters as descriptors led to a QSAR equation with remarkably increased predictive power (r2cv = 0.92). Additionally, ortho substitution of the propanolamine side chain and the acyl moiety is favorable. Detailed NMR spectroscopic investigations were carried out with the title compounds.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767638     DOI: 10.1021/jm980121y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  MCASE study of the multidrug resistance reversal activity of propafenone analogs.

Authors:  Gilles Klopman; Hao Zhu; Gerhard Ecker; Peter Chiba
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

2.  Quantitative structure-activity relationship and quantitative structure-pharmacokinetics relationship of 1,4-dihydropyridines and pyridines as multidrug resistance modulators.

Authors:  Xiao-Fei Zhou; Qingxiang Shao; Robert A Coburn; Marilyn E Morris
Journal:  Pharm Res       Date:  2005-09-20       Impact factor: 4.200

Review 3.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields.

Authors:  Fabio Broccatelli; Emanuele Carosati; Annalisa Neri; Maria Frosini; Laura Goracci; Tudor I Oprea; Gabriele Cruciani
Journal:  J Med Chem       Date:  2011-02-22       Impact factor: 7.446

5.  Annotating Human P-Glycoprotein Bioassay Data.

Authors:  Barbara Zdrazil; Marta Pinto; Poongavanam Vasanthanathan; Antony J Williams; Linda Zander Balderud; Ola Engkvist; Christine Chichester; Anne Hersey; John P Overington; Gerhard F Ecker
Journal:  Mol Inform       Date:  2012-08-07       Impact factor: 3.353

6.  Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.

Authors:  Ishrat Jabeen; Karin Pleban; Uwe Rinner; Peter Chiba; Gerhard F Ecker
Journal:  J Med Chem       Date:  2012-03-27       Impact factor: 7.446

7.  Prediction of promiscuous p-glycoprotein inhibition using a novel machine learning scheme.

Authors:  Max K Leong; Hong-Bin Chen; Yu-Hsuan Shih
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

8.  Crystal structure of [1-(3-chloro-phen-yl)-5-hy-droxy-3-methyl-1H-pyrazol-4-yl](p-tol-yl)methanone.

Authors:  Balbir Kumar; Kiran J Nakum; R N Jadeja; Rajni Kant; Vivek K Gupta
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-04-02

9.  2D- and 3D-QSAR studies of a series of benzopyranes and benzopyrano[3,4b][1,4]-oxazines as inhibitors of the multidrug transporter P-glycoprotein.

Authors:  Ishrat Jabeen; Penpun Wetwitayaklung; Peter Chiba; Manuel Pastor; Gerhard F Ecker
Journal:  J Comput Aided Mol Des       Date:  2013-02-12       Impact factor: 3.686

10.  Crystal structure of (Z)-1-(3,4-dichlorophenyl)-3-methyl-4-[(naphthalen-1-yl-amino)(p-tolyl)methylidene]-1H-pyrazol-5(4H)-one.

Authors:  Naresh Sharma; Sanjay Parihar; R N Jadeja; Rajni Kant; Vivek K Gupta
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.